▲ Peaking
Business
Kimberly-Clark closes its acquisition of Tylenol maker Kenvue. What to expect next
Kimberly-Clark has completed its acquisition of Kenvue, the maker of Tylenol, in a merger valued at over $40 billion.
1 trends tracked about this subject — the full history, oldest to newest below.
Kimberly-Clark has completed its acquisition of Kenvue, the maker of Tylenol, in a merger valued at over $40 billion.